Adam and Joanna take up a topic that's been bubbling up for some time: the impact of Ozempic and other GLP-1 drugs on the alcohol industry. As these drugs become easier to acquire and less stigmatized, are they having a noticeable impact on alcohol sales. Please remember to subscribe to, rate, and review VinePair on Apple Podcasts, Spotify, or wherever you get your episodes, and send any questions, comments, critiques, or suggestions to [email protected]. Thanks for listening, and be well.

Please remember to enter VinePair's Best New Bartender Competition, presented by Luxardo - submissions are due April 18th.

Joanna is reading: 8 Things We Learned From Trying 32 of NYC’s Best Martinis

Adam is reading: Champagne Sales Are Slumping. Is Prosecco to Blame?

Instagram: @adamteeter, @jcsciarrino, @zgeballe, @vinepair

Hosted on Acast. See acast.com/privacy for more information.